Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo Neurotoxic Effects of Paraoxon.

Farizatto KLG, McEwan SA, Naidoo V, Nikas SP, Shukla VG, Almeida MF, Byrd A, Romine H, Karanian DA, Makriyannis A, Bahr BA.

J Mol Neurosci. 2017 Sep;63(1):115-122. doi: 10.1007/s12031-017-0963-4. Epub 2017 Aug 12.

PMID:
28803438
2.

Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors.

Zuhl AM, Nolan CE, Brodney MA, Niessen S, Atchison K, Houle C, Karanian DA, Ambroise C, Brulet JW, Beck EM, Doran SD, O'Neill BT, Am Ende CW, Chang C, Geoghegan KF, West GM, Judkins JC, Hou X, Riddell DR, Johnson DS.

Nat Commun. 2016 Oct 11;7:13042. doi: 10.1038/ncomms13042.

3.

Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.

Naidoo V, Karanian DA, Vadivel SK, Locklear JR, Wood JT, Nasr M, Quizon PM, Graves EE, Shukla V, Makriyannis A, Bahr BA.

Neurotherapeutics. 2012 Oct;9(4):801-13. doi: 10.1007/s13311-011-0100-y.

4.

A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity.

Naidoo V, Nikas SP, Karanian DA, Hwang J, Zhao J, Wood JT, Alapafuja SO, Vadivel SK, Butler D, Makriyannis A, Bahr BA.

J Mol Neurosci. 2011 Mar;43(3):493-502. doi: 10.1007/s12031-010-9472-4. Epub 2010 Nov 11.

5.

Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS.

Williams J, Wood J, Pandarinathan L, Karanian DA, Bahr BA, Vouros P, Makriyannis A.

Anal Chem. 2007 Aug 1;79(15):5582-93. Epub 2007 Jun 29.

PMID:
17600384
6.

Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage.

Karanian DA, Karim SL, Wood JT, Williams JS, Lin S, Makriyannis A, Bahr BA.

J Pharmacol Exp Ther. 2007 Sep;322(3):1059-66. Epub 2007 Jun 1.

PMID:
17545313
7.

Memory impairments and hippocampal modifications in adult rats with neonatal isolation stress experience.

Kosten TA, Karanian DA, Yeh J, Haile CN, Kim JJ, Kehoe P, Bahr BA.

Neurobiol Learn Mem. 2007 Sep;88(2):167-76. Epub 2007 May 31.

PMID:
17543553
8.

Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers.

Butler D, Bendiske J, Michaelis ML, Karanian DA, Bahr BA.

Eur J Pharmacol. 2007 May 7;562(1-2):20-7. Epub 2007 Feb 8.

PMID:
17336290
9.
10.

3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.

Karanian DA, Baude AS, Brown QB, Parsons CG, Bahr BA.

Hippocampus. 2006;16(10):834-42.

PMID:
16897723
11.

Targeting the endocannabinoid system in treating brain disorders.

Bahr BA, Karanian DA, Makanji SS, Makriyannis A.

Expert Opin Investig Drugs. 2006 Apr;15(4):351-65. Review.

PMID:
16548785
12.

Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation.

Butler D, Brown QB, Chin DJ, Batey L, Karim S, Mutneja MS, Karanian DA, Bahr BA.

Rejuvenation Res. 2005 Winter;8(4):227-37.

PMID:
16313222
13.

Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity.

Karanian DA, Brown QB, Makriyannis A, Kosten TA, Bahr BA.

J Neurosci. 2005 Aug 24;25(34):7813-20.

14.

Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus.

Karanian DA, Brown QB, Makriyannis A, Bahr BA.

Eur J Pharmacol. 2005 Jan 31;508(1-3):47-56. Epub 2005 Jan 7.

PMID:
15680253
15.

Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour.

Sutton MA, Schmidt EF, Choi KH, Schad CA, Whisler K, Simmons D, Karanian DA, Monteggia LM, Neve RL, Self DW.

Nature. 2003 Jan 2;421(6918):70-5.

PMID:
12511956
16.

Extinction training regulates tyrosine hydroxylase during withdrawal from cocaine self-administration.

Schmidt EF, Sutton MA, Schad CA, Karanian DA, Brodkin ES, Self DW.

J Neurosci. 2001 Apr 1;21(7):RC137.

17.

Effects of the novel D1 dopamine receptor agonist ABT-431 on cocaine self-administration and reinstatement.

Self DW, Karanian DA, Spencer JJ.

Ann N Y Acad Sci. 2000;909:133-44.

PMID:
10911927
18.

Factors that determine a propensity for cocaine-seeking behavior during abstinence in rats.

Sutton MA, Karanian DA, Self DW.

Neuropsychopharmacology. 2000 Jun;22(6):626-41.

Supplemental Content

Loading ...
Support Center